Price $2.08 |
Market Cap
3.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.12
|
P/S
0.26
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-5.3K
|
FCF
-10.0
|
|
Op. Margin
-67.60%
|
Net Margin
-70.30%
|
ROE
-34.30%
|
ROI
-34.40%
|
|
ROA
-28.50%
|
EPS Growth
40.30%
|
Current Ratio
4.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Helius Medical Technologies In (HSDT) | $8.45 | - | - | 5.4M | Strong Buy |
| ProQR Therapeutics NV (PRQR) | $1.54 | - | - | 131.1M | Strong Buy |
| Star Equity Holdings Inc (STRR) | $1.09 | - | - | 16M | Strong Buy |
| Chromadex Corp (CDXC) | $1.42 | - | - | 117.7M | Strong Buy |
| Applied DNA Sciences Inc (APDN) | $1.26 | - | - | 16.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
